262
Views
7
CrossRef citations to date
0
Altmetric
Microbiology & Food Safety

Antimicrobial resistance of Campylobacter isolates recovered from broilers in the Republic of Ireland in 2017 and 2018: an update

ORCID Icon, , , , ORCID Icon, ORCID Icon & ORCID Icon show all
Pages 550-556 | Received 24 Oct 2019, Accepted 05 Mar 2020, Published online: 15 May 2020

References

  • Aarestrup, F. M., and J. Engberg. 2001. “Antimicrobial Resistance of Thermophilic Campylobacter.” Veterinary Research 32 (3–4): 311–321. doi:10.1051/vetres:2001127.
  • Acheson, D., and B. M. Allos. 2001. “Campylobacter Jejuni Infections: Update on Emerging Issues and Trends.” Clinical Infectious Diseases 32 (8): 1201–1206. doi:10.1086/319760.
  • Beechinor, J. G. 2009. Report on Consumption of Veterinary Antimicrobial Drugs in Ireland in 2009. Dublin. http://www.hpra.ie/docs/default-source/default-document-library/report-on-consumption-of-veterinary-antimicrobial-drugs-in-ireland-in-2009.pdf?sfvrsn=2
  • Bolinger, H., S. Kathariou, and D. W. Schaffner. 2017. “The Current State of Macrolide Resistance in Campylobacter Spp.: Trends and Impacts of Resistance Mechanisms.” Applied and Environmental Microbiology 83 (12): e00416–17. doi:10.1128/AEM.00416-17.
  • Bolton, D., A. Patriarchi, Á. Fox, and S. Fanning. 2013. “A Study of the Molecular Basis of Quinolone and Macrolide Resistance in A Selection of Campylobacter Isolates from Intensive Poultry Flocks.” Food Control 30 (1): 222–226. doi:10.1016/J.FOODCONT.2012.06.044.
  • Carvalho, I. T., and L. Santos. 2016. “Antibiotics in the Aquatic Environments: A Review of the European Scenario.” Environment International 94: 736–757. doi:10.1016/J.ENVINT.2016.06.025.
  • Casagrande Proietti, P., S. Pergola, S. Bellucci, L. Menchetti, D. Miraglia, and M. P. Franciosini. 2018. “Occurrence and Antimicrobial Susceptibility of Campylobacter Spp. On Fresh and Refrigerated Chicken Meat Products in Central Italy.” Poultry Science 97 (8): 2895–2901. doi:10.3382/ps/pey147.
  • Casewell, M., C. Friis, E. Marco, P. McMullin, and I. Phillips. 2003. “The European Ban on Growth-Promoting Antibiotics and Emerging Consequences for Human and Animal Health.” Journal of Antimicrobial Chemotherapy 52 (2): 159–161. doi:10.1093/jac/dkg313.
  • Chen, H. R., T. Rairat, S. H. Loh, Y. C. Wu, T. W. Vickroy, and C. C. Chou. 2017. “Assessment of Veterinary Drugs in Plants Using Pharmacokinetic Approaches: The Absorption, Distribution and Elimination of Tetracycline and Sulfamethoxazole in Ephemeral Vegetables.” PloS One 12 (8): e0183087. doi:10.1371/journal.pone.0183087.
  • Corcoran, D., T. Quinn, L. Cotter, P. Whyte, and S. Fanning. 2006. “Antimicrobial Resistance Profiling and Fla-Typing of Irish Thermophillic Campylobacter Spp. Of Human and Poultry Origin.” Letters in Applied Microbiology 43 (5): 560–565. doi:10.1111/j.1472-765X.2006.01987.x.
  • Council of the European Union. 1970. “Council Directive 70/524/EEC of 23 November 1970 Concerning Additives in Feeding-Stuffs.” Official Journal of the European Union L 270. Brussels: 840–856.
  • Crespo, M. D., E. Altermann, J. Olson, W. G. Miller, K. Chandrashekhar, and S. Kathariou. 2016. “Novel Plasmid Conferring Kanamycin and Tetracycline Resistance in the Turkey-Derived Campylobacter Jejuni Strain 11601MD.” Plasmid 86: 32–37. doi:10.1016/J.PLASMID.2016.06.001.
  • Department of Agriculture Food and the Marine, and Department of Health. 2019. One Health Report on Antimicrobial Use and Antimicrobial Resistance. https://www.gov.ie/en/publication/98f5bb-one-health-report-on-antimicrobial-use-antimicrobial-resistance/?referrer=/blog/publications/one-health-report-on-antimicrobial-use-antimicrobial-resistance/
  • ECDC. 2016. EU Protocol for Harmonised Monitoring of Antimicrobial Resistance in Human Salmonella and Campylobacter Isolates. Stockholm. doi:10.2900/516074.
  • ECDC, EFSA, and EMA. 2017. “ECDC/EFSA/EMA Second Joint Report on the Integrated Analysis of the Consumption of Antimicrobial Agents and Occurrence of Antimicrobial Resistance in Bacteria from Humans and Food‐producing Animals (JIACRA Report).” EFSA Journal. doi:10.2903/j.efsa.2017.4872.
  • EFSA. 2010. “Analysis of the Baseline Survey on the Prevalence of Campylobacter in Broiler Batches and of Campylobacter and Salmonella on Broiler Carcasses in the EU.” EFSA Journal 8: 3. doi:10.2903/j.efsa.2010.1503.
  • EFSA. 2011. “Scientific Opinion on Campylobacter in Broiler Meat Production: Control Options and Performance Objectives And/or Targets at Different Stages of the Food Chain.” EFSA Journal 94 (4): 8–32. doi:10.2903/j.efsa.2011.2105.
  • EFSA, and ECDC. 2013. “The European Union Summary Report on Antimicrobial Resistance in Zoonotic and Indicator Bacteria from Humans, Animals and Food in 2011.” EFSA Journal 11(5). doi:10.2903/j.efsa.2013.3196.
  • EFSA, and ECDC. 2018. “European Union Summary Report on Antimicrobial Resistance in Zoonotic and Indicator Bacteria from Humans, Animals and Food in 2016.” EFSA Journal 16(2). doi:10.2903/j.efsa.2018.5182.
  • Elhadidy, M., W. G. Miller, H. Arguello, A. Álvarez-Ordóñez, A. Duarte, K. Dierick, and N. Botteldoorn. 2018. “Genetic Basis and Clonal Population Structure of Antibiotic Resistance in Campylobacter Jejuni Isolated from Broiler Carcasses in Belgium.” Frontiers in Microbiology 9: 1014. doi:10.3389/fmicb.2018.01014.
  • EMA. 1998. Enrofloxacin (Modification for Bovine, Porcine and Poultry): Summary Report (2). Committee for Veterinary Medicinal Products. London. https://www.ema.europa.eu/documents/mrl-report/enrofloxacin-modification-bovine-porcine-poultry-summary-report-2-committee-veterinary-medicinal_en.pdf
  • EMA. 2014. Enrofloxacin Article 35 Referral - Opinion following an Article 35 Referral for All Veterinary Medicinal Products Containing Enrofloxacin to Be Administered via the Drinking Water to Chickens And/or Turkeys. London. https://www.ema.europa.eu/documents/referral/enrofloxacin-article-35-referral-opinion-following-article-35-referral-all-veterinary-medicines/turkeys_en.pdf
  • EMA. 2016a. ESVAC Vision, Strategy and Objectives 2016-2020. London. https://www.ema.europa.eu/documents/regulatory-procedural-guideline/european-surveillance-veterinary-antimicrobial-consumption-esvac-vision-strategy-2016-2020_en.pdf6299/2015_en.pdf
  • EMA. 2016b. Report on ESVAC Trial for Collecting Data on Consumption of Antimicrobial Agents in Pigs. London. https://www.ema.europa.eu/documents/report/report-esvac-trial-collecting-data-consumption-antimicrobial-agents-pigs_en.pdf
  • Endtz, H. P., G. J. Ruijs, B. van Klingeren, W. H. Jansen, T. van der Reyden, and R. P. Mouton. 1991. “Quinolone Resistance in Campylobacter Isolated from Man and Poultry following the Introduction of Fluoroquinolones in Veterinary Medicine.” Journal of Antimicrobial Chemotherapy 27 (2): 199–208. doi:10.1093/jac/27.2.199.
  • European Commission. 2013. “Commission Implementing Decision of 12 November 2013 on the Monitoring and Reporting of Antimicrobial Resistance in Zoonotic and Commensal Bacteria.” Official Journal of the European Union L 303. Brussels: 26–39.
  • European Commission. 2014. “Commission Implmenting Decision Concerning, in the Framework of Article 35 of Directive 2001/82/EC of the European Parliament and of the Council, the Marketing Authorisations for ‘HIPRALONA ENRO-S and Its Generics’ Veterinary Medicinal Products Which Cont.” Official Journal of the European Union L 311. Brussels: 1–3.
  • European Parliament, and Council of the European Union. 2003. “Regulation (EC) No 1831/2003 of the European Parliament and of the Council of 22 September 2003 on Additives for Use in Animal Nutrition.” Official Journal of the European Union L 268: 1–26.
  • Fairchild, A. S., J. L. Smith, U. Idris, J. Lu, S. Sanchez, L. B. Purvis, C. Hofacre, and M. D. Lee. 2005. “Effects of Orally Administered Tetracycline on the Intestinal Community Structure of Chickens and on Tet Determinant Carriage by Commensal Bacteria and Campylobacter Jejuni.” Applied and Environmental Microbiology 71 (10): 5865–5872. doi:10.1128/AEM.71.10.5865-5872.2005.
  • Fallon, R., N. O’Sullivan, M. Maher, and C. Carroll. 2003. “Antimicrobial Resistance of Campylobacter Jejuni and Campylobacter Coli Isolates from Broiler Chickens Isolated at an Irish Poultry Processing Plant.” Letters in Applied Microbiology 36 (5): 277–281. doi:10.1046/j.1472-765X.2003.01308.x.
  • García-Sánchez, L., B. Melero, A. M. Diez, I. Jaime, and J. Rovira. 2018. “Characterization of Campylobacter Species in Spanish Retail from Different Fresh Chicken Products and Their Antimicrobial Resistance.” Food Microbiology 76: 457–465. doi:10.1016/J.FM.2018.07.004.
  • Giacomelli, M., C. Salata, M. Martini, C. Montesissa, and A. Piccirillo. 2014. “Antimicrobial Resistance of Campylobacter Jejuni and Campylobacter Coli from Poultry in Italy.” Microbial Drug Resistance 20 (2): 181–188. doi:10.1089/mdr.2013.0110.
  • Gibreel, A., V. N. Kos, M. Keelan, C. A. Trieber, S. Levesque, S. Michaud, and D. E. Taylor. 2005. “Macrolide Resistance in Campylobacter Jejuni and Campylobacter Coli: Molecular Mechanism and Stability of the Resistance Phenotype.” Antimicrobial Agents and Chemotherapy 49 (7): 2753–2759. doi:10.1128/AAC.49.7.2753-2759.2005.
  • Gibreel, A., and D. E. Taylor. 2006. “Macrolide Resistance in Campylobacter Jejuni and Campylobacter Coli.” Journal of Antimicrobial Chemotherapy 58 (2): 243–255. doi:10.1093/jac/dkl210.
  • Gibreel, A., D. M. Tracz, L. Nonaka, T. M. Ngo, S. R. Connell, and D. E. Taylor. 2004. “Incidence of Antibiotic Resistance in Campylobacter Jejuni Isolated in Alberta, Canada, from 1999 to 2002, with Special Reference to Tet(O)-Mediated Tetracycline Resistance.” Antimicrobial Agents and Chemotherapy 48 (9): 3442–3450. doi:10.1128/AAC.48.9.3442-3450.2004.
  • Granados-Chinchilla, F., and C. Rodríguez. 2017. “Tetracyclines in Food and Feedingstuffs: From Regulation to Analytical Methods, Bacterial Resistance, and Environmental and Health Implications.” Journal of Analytical Methods in Chemistry 2017: 1315497. doi:10.1155/2017/1315497.
  • Grenni, P., V. Ancona, and A. Barra Caracciolo. 2018. “Ecological Effects of Antibiotics on Natural Ecosystems: A Review.” Microchemical Journal 136: 25–39. doi:10.1016/J.MICROC.2017.02.006.
  • Han, F., S. Pu, F. Wang, J. Meng, and B. Ge. 2009. “Fitness Cost of Macrolide Resistance in Campylobacter Jejuni.” International Journal of Antimicrobial Agents 34 (5): 462–466. doi:10.1016/J.IJANTIMICAG.2009.06.019.
  • Hao, H., M. Dai, Y. Wang, D. Peng, Z. Liu, and Z. Yuan. 2009. “23S RRNA Mutation A2074C Conferring High-Level Macrolide Resistance and Fitness Cost in Campylobacter JejuniHao, Haihong, Menghong Dai, Yulian Wang, Dapeng Peng, Zhenli Liu, and Zonghui Yuan. 2009. “23S RRNA Mutation A2074C Conferring High-Level Macrolide.” Microbial Drug Resistance 15 (4): 239–244. doi:10.1089/mdr.2009.0008.
  • HPRA. 2014. Report on Consumption of Veterinary Antibiotics in Ireland during 2014. Dublin. https://www.hpra.ie/docs/default-source/publications-forms/newsletters/report-on-consumption-of-veterinary-antibiotics-in-ireland-during-2014.pdf?sfvrsn=9
  • HPRA. 2016. Report on Consumption of Veterinary Antibiotics in Ireland during 2016. Dublin. https://www.hpra.ie/docs/default-source/default-document-library/report-on-consumption-of-veterinary-antibiotics-in-ireland-during-2016367b0a2697826eee9b55ff00008c97d0.pdf?sfvrsn=0
  • HPRA. 2017. Report on Consumption of Veterinary Antibiotics in Ireland during 2017. Dublin. http://www.hpra.ie/docs/default-source/default-document-library/draft-report-on-consumption-of-veterinary-antibiotics-in-ireland-during-2017.pdf?sfvrsn=0
  • Jjemba, P. K. 2002. “The Potential Impact of Veterinary and Human Therapeutic Agents in Manure and Biosolids on Plants Grown on Arable Land: A Review.” Agriculture, Ecosystems & Environment 93 (1–3): 267–278. doi:10.1016/S0167-8809(01)00350-4.
  • Jorgensen, F., J. Ellis-Iversen, S. Rushton, S. A. Bull, S. A. Harris, S. J. Bryan, A. Gonzalez, and T. J. Humphrey. 2011. “Influence of Season and Geography on Campylobacter Jejuni and C. Coli Subtypes in Housed Broiler Flocks Reared in Great Britain.” Applied and Environmental Microbiology 77 (11): 3741–3748. doi:10.1128/AEM.02444-10.
  • Kemper, N. 2008. “Veterinary Antibiotics in the Aquatic and Terrestrial Environment.” Ecological Indicators 8 (1): 1–13. doi:10.1016/j.ecolind.2007.06.002.
  • Kuppusamy, S., D. Kakarla, K. Venkateswarlu, M. Megharaj, Y. E. Yoon, and Y. B. Lee. 2018. “Veterinary Antibiotics (Vas) Contamination as A Global Agro-Ecological Issue: A Critical View.” Agriculture, Ecosystems & Environment 257: 47–59. doi:10.1016/J.AGEE.2018.01.026.
  • Lin, J., M. Yan, O. Sahin, S. Pereira, Y. J. Chang, and Q. Zhang. 2007. “Effect of Macrolide Usage on Emergence of Erythromycin-Resistant Campylobacter Isolates in Chickens.” Antimicrobial Agents and Chemotherapy 51 (5): 1678–1686. doi:10.1128/AAC.01411-06.
  • Luangtongkum, T., B. Jeon, J. Han, P. Plummer, C. M. Logue, and Q. Zhang. 2009. “Antibiotic Resistance in Campylobacter: Emergence, Transmission and Persistence.” Future Microbiology 4 (2): 189–200. doi:10.2217/17460913.4.2.189.
  • Luangtongkum, T., Z. Shen, V. W. Seng, O. Sahin, B. Jeon, P. Liu, and Q. Zhang. 2012. “Impaired Fitness and Transmission of Macrolide-Resistant Campylobacter Jejuni in Its Natural Host.” Antimicrobial Agents and Chemotherapy 56 (3): 1300–1308. doi:10.1128/AAC.05516-11.
  • Lucey, B., B. Cryan, F. O’Halloran, P. G. Wall, T. Buckley, and S. Fanning. 2002a. “Trends in Antimicrobial Susceptibility among Isolates of Campylobacter Species in Ireland and the Emergence of Resistance to Ciprofloxacin.” The Veterinary Record 151 (11): 317–320. doi:10.1136/vr.151.11.317.
  • Lucey, B., B. Cryan, F. O’Halloran, P. G. Wall, T. Buckley, and S. Fanning. 2002b. “Trends in Antimicrobial Susceptibility among Isolates of Campylobacter Species in Ireland and the Emergence of Resistance to Ciprofloxacin.” The Veterinary Record 151 (11): 317–320.
  • Lucey, B., C. Feurer, P. Greer, P. Moloney, B. Cryan, and S. Fanning. 2000. “Antimicrobial Resistance Profiling and DNA Amplification Fingerprinting (DAF) of Thermophilic Campylobacter Spp. In Human, Poultry and Porcine Samples from the Cork Region of Ireland.” Journal of Applied Microbiology 89 (5): 727–734. doi:10.1046/j.1365-2672.2000.01153.x.
  • Lucey, B., F. O’Halloran, and S. Fanning. 2004. “Molecular-Based Identification and Typing of Campylobacter Jejuni and C. Coli.” Public Health Microbiology 268 (5): 33–48. doi:10.1385/1-59259-766-1:033.
  • Luo, N., S. Pereira, O. Sahin, J. Lin, S. Huang, L. Michel, and Q. Zhang. 2005. “Enhanced in Vivo Fitness of Fluoroquinolone-Resistant Campylobacter Jejuni in the Absence of Antibiotic Selection Pressure.” Proceedings of the National Academy of Sciences of the United States of America 102 (3): 541–546. doi:10.1073/pnas.0408966102.
  • Luo, N., O. Sahin, J. Lin, L. O. Michel, and Q. Zhang. 2003. “In Vivo Selection of Campylobacter Isolates with High Levels of Fluoroquinolone Resistance Associated with GyrA Mutations and the Function of the CmeABC Efflux Pump.” Antimicrobial Agents and Chemotherapy 47 (1): 390–394. doi:10.1128/AAC.47.1.390-394.2003.
  • McGill, K., D. Cowley, L. Moran, P. Scates, A. O’Leary, R. H. Madden, C. Carroll, et al. 2006. “Antibiotic Resistance of Retail Food and Human Campylobacter Isolates on the Island of Ireland from 2001-2002.” Epidemiology and Infection 134 (6): 1282–1291. doi:10.1017/S0950268806006200.
  • Moore, J. E., D. Corcoran, J. S. G. Dooley, S. Fanning, B. Lucey, M. Matsuda, D. A. McDowell, et al. 2005. “Campylobacter.” Veterinary Research 36 (3): 351–382. doi:10.1051/vetres:2005012.
  • Moore, J. E., and M. Matsuda. 2004. “Fluoroquinolone Resistance in Environmental Urease-Positive Campylobacters: Why We Don’t See It.” Journal of Antimicrobial Chemotherapy 53 (5): 891–892. doi:10.1093/jac/dkh188.
  • Nielsen, H., K. K. Hansen, K. O. Gradel, B. Kristensen, T. Ejlertsen, C. Østergaard, and H. C. Schønheyder. 2010. “Bacteraemia as A Result of Campylobacter Species: A Population-Based Study of Epidemiology and Clinical Risk Factors.” Clinical Microbiology and Infection 16 (1): 57–61. doi:10.1111/j.1469-0691.2009.02900.x.
  • Ohno, H., J. I. Wachino, R. Saito, W. Jin, K. Yamada, K. Kimura, and Y. Arakawa. 2016. “A Highly Macrolide-Resistant Campylobacter Jejuni Strain with Rare A2074T Mutations in 23S RRNA Genes.” Antimicrobial Agents and Chemotherapy 60 (4): 2580–2581. doi:10.1128/AAC.02822-15.
  • Persoons, D., J. Dewulf, A. Smet, L. Herman, M. Heyndrickx, A. Martel, B. Catry, P. Butaye, and F. Haesebrouck. 2012. “Antimicrobial Use in Belgian Broiler Production.” Preventive Veterinary Medicine 105 (4): 320–325. doi:10.1016/j.prevetmed.2012.02.020.
  • Public Health England. 2018. “Antimicrobial Resistance in Campylobacter Jejuni and Campylobacter Coli from Retail Chilled Chicken in the UK (Year 3: 2016-17),” 1–19.
  • Sarmah, A. K., M. T. Meyer, and B. A. Boxall. 2006. “A Global Perspective on the Use, Sales, Exposure Pathways, Occurrence, Fate and Effects of Veterinary Antibiotics (Vas) in the Environment.” Chemosphere 65 (5): 725–759. doi:10.1016/j.chemosphere.2006.03.026.
  • Scanlan, E., L. Ardill, M. V. X. Whelan, C. Shortt, J. E. Nally, B. Bourke, and T. Ó. Cróinín. 2017. “Relaxation of DNA Supercoiling Leads to Increased Invasion of Epithelial Cells and Protein Secretion by Campylobacter Jejuni.” Molecular Microbiology 104 (1): 92–104. doi:10.1111/mmi.13614.
  • Sheppard, S. K., and M. C. J. Maiden. 2015. “The Evolution of Campylobacter Jejuni and Campylobacter Coli.” Cold Spring Harbor Perspectives in Biology 7 (8): a018119. doi:10.1101/cshperspect.a018119.
  • Sproston, E. L., H. M. L. Wimalarathna, and S. K. Sheppard. 2018. “Trends in Fluoroquinolone Resistance in Campylobacter.” Microbial Genomics 4 8. Microbiology Society. doi:10.1099/mgen.0.000198.
  • Stapleton, K., S. A. Cawthraw, S. W. Cooles, N. G. Coldham, R. M. La Ragione, D. G. Newell, and A. M. Ridley. 2010. “Selecting for Development of Fluoroquinolone Resistance in a Campylobacter Jejuni Strain 81116 in Chickens Using Various Enrofloxacin Treatment Protocols.” Journal of Applied Microbiology 109 (4): 1132–1138. doi:10.1111/j.1365-2672.2010.04734.x.
  • Taylor, N. M., A. D. Wales, A. M. Ridley, and R. H. Davies. 2016. “Farm Level Risk Factors for Fluoroquinolone Resistance in E. Coli and Thermophilic Campylobacter Spp. On Poultry Farms.” Avian Pathology 45 (5): 559–568. doi:10.1080/03079457.2016.1185510.
  • Thorsteinsdottir, T. R., K. G. Kristinsson, V. Fridriksdottir, and E. Gunnarsson. 2008. “Antimicrobial Resistance of Campylobacter Spp. Isolated from Broiler Flocks in Iceland 2001–2005.” Microbial Drug Resistance 14 (1): 49–53. doi:10.1089/mdr.2008.0791.
  • Torralbo, A., C. Borge, I. García-Bocanegra, G. Méric, A. Perea, and A. Carbonero. 2015. “Higher Resistance of Campylobacter Coli Compared to Campylobacter Jejuni at Chicken Slaughterhouse.” Comparative Immunology, Microbiology and Infectious Diseases 39: 47–52. doi:10.1016/J.CIMID.2015.02.003.
  • US Food and Drug Administration. 2005. “Withdrawal of Enrofloxacin for Poultry.” Silver Spring, MD: Center for Veterinary Medicine. https://www.fda.gov/animal-veterinary/recalls-withdrawals/withdrawal-enrofloxacin-poultry
  • Whelan, M. X., L. Ardill, K. Koide, C. Nakajima, Y. Suzuki, J. C. Simpson, and T. Ó. Cróinín. 2019. “Acquisition of Fluoroquinolone Resistance in Campylobacter Jejuni Leads to an Increase in Biofilm Formation and Virulence.” Scientific Reports 1 (1A): 1–13. doi:10.1099/acmi.ac2019.po0459.
  • Wimalarathna, H. M. L., J. F. Richardson, A. J. Lawson, R. Elson, R. Meldrum, C. L. Little, M. C. J. Maiden, N. D. McCarthy, and S. K. Sheppard. 2013. “Widespread Acquisition of Antimicrobial Resistance among Campylobacter Isolates from UK Retail Poultry and Evidence for Clonal Expansion of Resistant Lineages.” BMC Microbiology 13 (1): 160. doi:10.1186/1471-2180-13-160.
  • Woźniak-Biel, A., G. Bugla-Płoskońska, A. Kielsznia, K. Korzekwa, A. Tobiasz, A. Korzeniowska-Kowal, and A. Wieliczko. 2017. “High Prevalence of Resistance to Fluoroquinolones and Tetracycline Campylobacter Spp. Isolated from Poultry in Poland.” Microbial Drug Resistance. doi:10.1089/mdr.2016.0249.
  • Yao, H., D. Liu, Y. Wang, Q. Zhang, and Z. Shen. 2017. “High Prevalence and Predominance of the Aph(2)-If Gene Conferring Aminoglycoside Resistance in Campylobacter.” Antimicrobial Agents and Chemotherapy 61: 5. doi:10.1128/AAC.00112-17.
  • Zhang, Q., J. Lin, and S. Pereira. 2003. “Fluoroquinolone-Resistant Campylobacter in Animal Reservoirs: Dynamics of Development, Resistance Mechanisms and Ecological Fitness.” Animal Health Research Reviews 4 (2): 63–71. doi:10.1079/AHR200356.
  • Zirnstein, G., Y. Li, B. Swaminathan, and F. Angulo. 1999. “Ciprofloxacin Resistance in Campylobacter Jejuni Isolates: Detection of GyrA Resistance Mutations by Mismatch Amplification Mutation Assay PCR and DNA Sequence Analysis.” Journal of Clinical Microbiology 37 (10): 3276–3280. doi:10.1128/JCM.37.10.3276-3280.1999.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.